Evaluation of nanobody-based biologics targeting purinergic checkpoints in tumor models in vivo
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1012534
Abstract: Adenosine triphosphate (ATP) represents a danger signal that accumulates in injured tissues, in inflammatory sites, and in the tumor microenvironment. ATP promotes tumor growth but also anti-tumor immune responses notably via the P2X7 receptor. ATP… read more here.
Keywords: based biologics; purinergic checkpoints; p2x7; nanobody based ... See more keywords